Credit Agricole S A Amgen Inc Transaction History

Credit Agricole S A

$18.2 Billion
Q2 2024

A detailed history of Credit Agricole S A transactions in Amgen Inc stock. As of the latest transaction made, Credit Agricole S A holds 155,664 shares of AMGN stock, worth $49.9 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

155,664

Previous 61,468 153.24%

Holding current value

$49.9 Million

Previous $17.5 Million 178.31%

% of portfolio

0.27%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $24.7 Million - $30.1 Million	94,196 Added 153.24%	155,664 $48.6 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $44.5 Million - $53.7 Million	-165,493 Reduced 72.92%	61,468 $17.5 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $53 Million - $59.7 Million	207,085 Added 1041.88%	226,961 $65.4 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $3.16 Million - $3.92 Million	14,457 Added 266.78%	19,876 $5.34 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $34,283 - $40,539	160 Added 3.04%	5,419 $1.2 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $758,654 - $924,672	-3,360 Reduced 38.98%	5,259 $1.27 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $618,381 - $785,727	2,700 Added 45.62%	8,619 $2.26 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $113,801 - $128,347	507 Added 9.37%	5,919 $1.33 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $7,152 - $7,958	-31 Reduced 0.57%	5,412 $1.32 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $20,611 - $22,801	94 Added 1.76%	5,443 $1.32 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $120,720 - $138,153	-607 Reduced 10.19%	5,349 $1.2 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $489,070 - $573,004	-2,304 Reduced 27.89%	5,956 $1.27 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $578,344 - $641,630	2,476 Added 42.81%	8,260 $2.01 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $566,536 - $660,205	2,553 Added 79.02%	5,784 $1.44 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $71,098 - $79,067	303 Added 10.35%	3,231 $821,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $386,520 - $474,313	1,954 Added 200.62%	2,928 $691,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $3.83 Million - $5.09 Million	-21,039 Reduced 95.58%	974 $197,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $2.5 Million - $3.21 Million	-13,213 Reduced 37.51%	22,013 $5.31 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $5.92 Million - $7.09 Million	34,000 Added 2773.25%	35,226 $6.82 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $72,348 - $81,552	400 Added 48.43%	1,226 $233,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $121,312 - $141,610	-680 Reduced 45.15%	826 $161,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $741 - $835	-4 Reduced 0.26%	1,506 $313,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $108,430 - $121,791	-653 Reduced 30.19%	1,510 $279,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $383,758 - $448,470	-2,265 Reduced 51.15%	2,163 $369,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $100 Million - $112 Million	-593,406 Reduced 99.26%	4,428 $770,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $44.3 Million - $50.6 Million	-264,965 Reduced 30.71%	597,834 $111 Million
Q2 2017 Aug 14, 2017	BUY	N/A	862,799	862,799 $149 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.

Account

Credit Agricole S A Amgen Inc Transaction History